News | Peripheral Artery Disease (PAD) | March 22, 2022

The Cardiovascular Care Group Raises Awareness of Peripheral Artery Disease

Fifteen board-certified vascular surgeons focused on educating the community about the importance of screening for Peripheral Artery Disease (PAD).

With 60 years of experience, The Cardiovascular Care Group is nationally recognized for vascular and endovascular care. In addition to providing quality care to tens of thousands of patients over the years, The Cardiovascular Care Group has been committed to educating the community on vascular-related conditions through the sharing of knowledge and transparency.

March 22, 2022 – With 60 years of experience, The Cardiovascular Care Group is nationally recognized for vascular and endovascular care. In addition to providing quality care to tens of thousands of patients over the years, The Cardiovascular Care Group has been committed to educating the community on vascular-related conditions through the sharing of knowledge and transparency. Raising awareness of Peripheral Artery Disease (PAD) to prevent amputation is the latest in that effort.

“PAD impacts over 8 million Americans, is the leading cause of amputation and can be associated with a host of other issues such as heart disease and stroke,” said Clifford Sales MD, managing partner of The Cardiovascular Care Group. “As most people are unaware that they have PAD, we felt it prudent to bring it to the forefront of their attention, particularly how to recognize the risk factors and early warning signs.”

Peripheral artery disease, also known as peripheral vascular disease, is the narrowing or blockage of an artery in the leg resulting in reduced blood flow to that leg. This hardening of the artery (atherosclerosis) is a buildup of plaque inside the artery, which reduces the inner size of the artery over time. This plaque buildup occurs throughout the body and may cause heart attacks, strokes, and, in the case of PAD, gangrene and even the need for amputation.

Unfortunately, general awareness of PAD is low with only 25% of patients being diagnosed and treated, mainly due to a lack of symptoms and proper testing. The Cardiovascular Care Group believes consulting with a board-certified Vascular Surgeon, who specializes in this disease process, is a smart step in managing your overall health. In addition, they have developed an online PAD Self-Assessment tool to see if you or anyone you know has some of the PAD indicators.

The main risk factors for PAD include a family history of atherosclerosis, an inactive lifestyle, smoking, diabetes, high cholesterol and high blood pressure. PAD is more common after age 40 and can affect as much as 20% of the population over 65 years of age.

The most common symptoms of PAD are pain or cramping in the legs when walking or exercising (called claudication) that goes away with rest. However, many individuals may not have any symptoms until the artery has narrowed significantly.

For more information: tcvcg.com/

Related Content

News | Peripheral Artery Disease (PAD)

May 20, 2022 — New long-term data from the Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel ...

Home May 20, 2022
Home
News | Peripheral Artery Disease (PAD)

May 19, 2022 — One year outcomes from the Disrupt PAD III Trial comparing intravascular lithotripsy (IVL) with a drug ...

Home May 19, 2022
Home
News | Peripheral Artery Disease (PAD)
February 21, 2022 – A research group the Department of Cardiovascular Medicine, Osaka City University Graduate School of ...
Home February 21, 2022
Home
News | Peripheral Artery Disease (PAD)
February 15, 2022 – Alkem Laboratories Limited (Alkem), an Indian multinational pharmaceutical company, has signed a ...
Home February 15, 2022
Home
News | Peripheral Artery Disease (PAD)

January 17, 2022 – The Vascular Care Group (TVCG) announced Stephen J. Hoenig M.D., successfully completed a ...

Home January 17, 2022
Home
News | Peripheral Artery Disease (PAD)

October 20, 2021 — Boston Scientific Corporation announced positive data for the Eluvia Drug-Eluting Vascular Stent ...

Home October 20, 2021
Home
News | Peripheral Artery Disease (PAD)

June 7, 2021 — A couple years ago a study showed a mortality safety signal in patients who underwent peripheral artery ...

Home June 07, 2021
Home
News | Peripheral Artery Disease (PAD)

May 17, 2021 — The anticoagulant rivaroxaban (Xarelto), in addition to low-dose aspirin, significantly reduced the ...

Home May 17, 2021
Home
News | Peripheral Artery Disease (PAD)

January 26, 2021 — Pedra Technology, a privately held company, announced today that the U.S. Food and Drug ...

Home January 26, 2021
Home
News | Peripheral Artery Disease (PAD)

November 13, 2020 — The new U.S. Food and Drug Administration (FDA) cleared XO Score system was successfully used to ...

Home November 13, 2020
Home
Subscribe Now